Wednesday, October 28, 2026
Data from SEC filings, checked daily
Public filings, plainly told
Insider tradingForm 4

CORCEPT THERAPEUTICS INC (CORT) Insider Trading

17 open-market trades reported since Aug 18, 2026: 0 purchases worth $0 and 17 sales worth $39.9M.

By insider

InsiderRoleBuysBoughtSellsSoldLatest
James N. WilsonDirector0$03$3.37MOct 16, 2026
Sean MaduckSee Remarks0$05$10.1MOct 5, 2026
Joseph Douglas LyonSee Remarks0$03$2.30MOct 5, 2026
Roberto Wandenkolk VieiraPresident0$03$7.46MOct 5, 2026
Kimberly ParkDirector0$01$3.27MAug 28, 2026
David L. MahoneyDirector0$01$12.3MAug 20, 2026
Gary Charles RobbChief Business Officer0$01$1.16MAug 18, 2026
ADVERTISEMENT
728 × 90 ad slot320 × 100 ad slot

All trades

CORT insider trades
FiledTradedInsiderRoleTypeSharesPrice ($)ValueHolding3 mo. afterFiling
Oct 16Oct 15James N. WilsonDirectorDirector (ind.)▼ SELL10b5-110,000114.81$1.15M−0.9%Form 4 ↗
Oct 5Oct 2Sean MaduckSee RemarksSee Remarks▼ SELL10b5-124,587116.28$2.86M−71%Form 4 ↗
Oct 5Oct 2Joseph Douglas LyonSee RemarksSee Remarks▼ SELL10b5-19,190116.13$1.07M−62%Form 4 ↗
Oct 5Oct 2Roberto Wandenkolk VieiraPresidentPresident▼ SELL10b5-18,333116.10$967K−68%Form 4 ↗
Oct 5Oct 1Joseph Douglas LyonSee RemarksSee Remarks▼ SELL10b5-1810115.40$93K−13%Form 4 ↗
Oct 5Oct 1Sean MaduckSee RemarksSee Remarks▼ SELL10b5-1413115.54$48K−4.0%Form 4 ↗
Sep 18Sep 16Roberto Wandenkolk VieiraPresidentPresident▼ SELL10b5-1296100.82$30K−7.0%Form 4 ↗
Sep 16Sep 14Joseph Douglas LyonSee RemarksSee Remarks▼ SELL10b5-110,000113.49$1.13M−64%Form 4 ↗
Sep 16Sep 15James N. WilsonDirectorDirector (ind.)▼ SELL10b5-110,000110.69$1.11M−0.9%Form 4 ↗
Sep 3Sep 2Roberto Wandenkolk VieiraPresidentPresident▼ SELL10b5-158,333110.76$6.46M−91%Form 4 ↗
Sep 3Sep 1Sean MaduckSee RemarksSee Remarks▼ SELL10b5-125,000114.43$2.86M−72%Form 4 ↗
Aug 28Aug 26Kimberly ParkDirectorDirector▼ SELL26,685122.55$3.27MAll soldForm 4 ↗
Aug 27Aug 25Sean MaduckSee RemarksSee Remarks▼ SELL10b5-130,955125.58$3.89M−76%Form 4 ↗
Aug 20Aug 18David L. MahoneyDirectorDirector (ind.)▼ SELL10b5-1103,606118.25$12.3M−8.4%Form 4 ↗
Aug 18Aug 17Gary Charles RobbChief Business OfficerChief Business Officer (ind.)▼ SELL10,000116.26$1.16M−20%Form 4 ↗
Aug 18Aug 14James N. WilsonDirectorDirector (ind.)▼ SELL10b5-110,000111.43$1.11M−0.9%Form 4 ↗
Aug 18Aug 14Sean MaduckSee RemarksSee Remarks▼ SELL10b5-13,664114.49$419K−27%Form 4 ↗
Source: SEC Form 4 filings, retrieved Oct 28, 2026. How we read filings